Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
148M
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
17.3M
-
Shares change
-
-19.4K
-
Total reported value, excl. options
-
$226M
-
Value change
-
-$710K
-
Number of buys
-
17
-
Number of sells
-
-23
-
Price
-
$13.07
Significant Holders of 89bio, Inc. - Common stock, par value $0.001 per share (ETNB) as of Q4 2021
54 filings reported holding ETNB - 89bio, Inc. - Common stock, par value $0.001 per share as of Q4 2021.
89bio, Inc. - Common stock, par value $0.001 per share (ETNB) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.3M shares
of 148M outstanding shares and own 11.67% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (4.97M shares), ORBIMED ADVISORS LLC (3.73M shares), WELLINGTON MANAGEMENT GROUP LLP (2.15M shares), BlackRock Inc. (852K shares), FRANKLIN RESOURCES INC (804K shares), EVENTIDE ASSET MANAGEMENT, LLC (717K shares), FMR LLC (638K shares), VANGUARD GROUP INC (516K shares), Candriam Luxembourg S.C.A. (488K shares), and CITADEL ADVISORS LLC (270K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.